Access to European Union law
<a href="https://eur-lex.europa.eu/content/help/eurlex-content/experimental-features.html" target="_blank">More about the experimental features corner</a>
Choose the experimental features you want to try
EUR-Lex
Access to European Union law

This document is an excerpt from the EUR-Lex website

You are here
Use quotation marks to search for an "exact phrase". Append an asterisk (*) to a search term to find variations of it (transp*, 32019R*). Use a question mark (?) instead of a single character in your search term to find variations of it (ca?e finds case, cane, care).
Search tips
Need more search options? Use the Advanced search

Document 62019TB0712

    Byla T-712/19: 2022 m. rugsėjo 14 d. Bendrojo Teismo nutartis byloje Hikma Pharmaceuticals ir Hikma Pharmaceuticals International / Komisija

    OL C 432, 2022 11 14, p. 39–39 (BG, ES, CS, DA, DE, ET, EL, EN, FR, GA, HR, IT, LV, LT, HU, MT, NL, PL, PT, RO, SK, SL, FI, SV)

    2022 11 14   

    LT

    Europos Sąjungos oficialusis leidinys

    C 432/39

    2022 m. rugsėjo 14 d. Bendrojo Teismo nutartis byloje Hikma Pharmaceuticals ir Hikma Pharmaceuticals International / Komisija

    (Byla T-712/19) (1)

    (2022/C 432/47)

    Proceso kalba: anglų

    Antrosios kolegijos pirmininkė nutartimi nurodė išbraukti bylą iš registro.

    (1)  OL C 10, 2020 1 13.

    Top